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ABSTRACT 
In support of the NASA Human Research Program Exploration Medical Capability (ExMC) Element, NASA Ames 
Research Center (ARC) established a collaborative effort with the Canadian Space Agency (CSA).  The collaboration 
focuses on leveraging CSA capability in the areas of biosensors and decision support that will augment future 
development of such components for Exploration Missions.  The CSA advancement of biosensors enables NASA to 
focus on the integration and data management associated with these types of components through the system currently 
under development by the Medical Data Architecture (MDA) project.  This approach has enabled the establishment 
of a successful collaborative working relationship between ExMC and CSA. 
 
Applying lessons learned from the fiscal year 2016 (FY16) Human Exploration Research Analog (HERA) campaign, 
CSA and NASA ARC developed a solution to provide real-time feedback to researchers who monitor the collection 
of vital signs data from a wearable Astroskin garment.  The advances in the interfaces included the development of an 
iPad application (by CSA) to wirelessly forward the vital signs data to the MDA system, which collected the vital 
signs data through a receiver developed by NASA ARC.  The development of these interfaces aims to provide 
communications between the Astroskin and the MDA system such that data may be seamlessly collected, stored and 
retrieved by the MDA.  The first steps towards this goal were demonstrated in FY16.  In FY17, ExMC will complete 
the first in a series of test beds that establishes a system to automate collection and management of vital sign data from 
the Astroskin, and other sources of data, to provide information for a crewmember to make medical decisions.  In 
addition, the MDA Test Bed 1 will enable CSA to evaluate and optimize biosensor advancement and facilitate decision 
support algorithm development. 
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